These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10315384)

  • 1. FDA lifts restrictions on AFP test for fetal screening.
    MLO Med Lab Obs; 1983 Aug; 15(8):27-9. PubMed ID: 10315384
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA study finds test kits effective in spotting birth defects.
    Public Health Rep; 1998; 113(5):382. PubMed ID: 9769758
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on genetic screening: an FDA approved kit, views on early diagnosis.
    Bermel J
    Hastings Cent Rep; 1983 Oct; 13(5):3-4. PubMed ID: 11644083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AFP kit restrictions draw industry opposition.
    Pollner F
    Am Pharm; 1981 Apr; NS21(4):6-7. PubMed ID: 6164282
    [No Abstract]   [Full Text] [Related]  

  • 5. The crucial protocol for prenatal AFP screening.
    Rowe TF; Greenberg F
    MLO Med Lab Obs; 1983 Sep; 15(9):43-4, 47-50. PubMed ID: 10315418
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical devices; immunology and microbiology devices; classification of AFP-L3% immunological test systems. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(191):57748-50. PubMed ID: 16206426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The link between providers and patients: how laboratories can ensure quality results with genetic testing.
    Quillin JM; Jackson-Cook C; Bodurtha J
    Clin Leadersh Manag Rev; 2003; 17(6):351-7. PubMed ID: 14692080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA offers CLIA test categorization database, CMS plans inspections in waived and PPMP laboratories, and ICD.9 coding is clarified.
    Pontius CA
    MLO Med Lab Obs; 2001 Nov; 33(11):34, 37. PubMed ID: 11721283
    [No Abstract]   [Full Text] [Related]  

  • 9. Very low alpha-fetoprotein in Down syndrome maternal serum screening.
    Muller F; Dreux S; Sault C; Galland A; Puissant H; Couplet G; Lemay C; Larcher ME; Renom G;
    Prenat Diagn; 2003 Jul; 23(7):584-7. PubMed ID: 12868089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA and clinical labs: beginning a dialogue.
    Javitt G
    MLO Med Lab Obs; 2007 May; 39(5):52, 50. PubMed ID: 18396740
    [No Abstract]   [Full Text] [Related]  

  • 11. Unapproved tests on a chip.
    Nature; 2005 Dec; 438(7069):711. PubMed ID: 16340967
    [No Abstract]   [Full Text] [Related]  

  • 12. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
    Spencer K
    Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA issues good laboratory practice (GLP) regulations.
    Vet Hum Toxicol; 1979 Apr; 21(2):99. PubMed ID: 442484
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
    Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Picture perfect: the politics of prenatal testing.
    Kristol E
    First Things; 1993 Apr; 32():17-24. PubMed ID: 11659558
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenatal trisomy 21 screening using the Lens culinaris agglutinin-reactive alpha-fetoprotein ratio.
    Yamamoto R; Minobe S; Ebina Y; Watari H; Kudo M; Henmi F; Satomura S; Fujimoto S; Minakami H; Sakuragi N
    Congenit Anom (Kyoto); 2004 Jun; 44(2):87-92. PubMed ID: 15198721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approval of AFP test kits raises concern.
    Ob Gyn News; 1983 Aug 1-14; 18(15):3, 42. PubMed ID: 11653456
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of umbilical cord alpha fetoprotein as a screening tool for neonatal hyperbilirubinemia.
    Riskin A; David M; Peskin B; Tamir A; Vafsi O; Leibovitz Z; Riskin-Mashiah S; Israel N; Merksamer R; Bader D
    Am J Perinatol; 2004 Feb; 21(2):93-8. PubMed ID: 15017473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA approves alpha-fetoprotein kit amid physician, consumer concerns.
    Med World News; 1983 Jul; 24(14):59. PubMed ID: 11645669
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
    Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC
    Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.